FDA clears Coreline Soft's AVIEW Aorta Metrics software

Coreline Soft has secured 510(k) clearance from the US FDA for its aortic quantitative analysis tool, AVIEW Aorta Metrics. The regulatory clearance brings Coreline Soft’s total to 13 FDA 510(k) clearances and broadens its chest AI portfolio. AVIEW Aorta Metrics segments the aorta using chest CT scans. Credit: Near D Krasaesom / Shutterstock.com. Coreline Soft has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its aortic quantitative analysis tool, AVIEW Aorta Metrics. The regulatory clearance brings the company’s total to 13 FDA 510(k) clearances and broadens its chest computed tomography (CT) AI portfolio in the US.…

Source: Medical Device Network